Savers Value Village (SVV) 10b5-1 sales and option disclosures by General Counsel
Rhea-AI Filing Summary
Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV) reported multiple insider transactions executed under a 10b5-1 plan. On 08/29/2025 he purchased 15,000 shares at $1.41 and concurrently sold 15,000 shares at a weighted-average price of $11.98, leaving 0 shares of common stock after that trade. On 09/02/2025 he purchased 17,500 shares at $1.41 and sold 17,500 shares at a weighted-average price of $12.5093, again resulting in 0 shares held following those trades. The filing also reports two stock option groupings exercisable into common stock: 15,000 options and 17,500 options exercisable at $1.41, and a reported total of 419,256 and 401,756 shares underlying options following the respective transactions.
Positive
- Sales executed under a recorded 10b5-1 plan (March 10, 2025) which provides procedural compliance and pre-clearance for trades
- Options and exercisable rights remain substantial, with 419,256 and 401,756 underlying shares reported after the transactions, showing alignment with incentive awards
- Disclosures include weighted-average sale prices and execution ranges, with the filer offering to provide per-price execution details on request
Negative
- After paired purchase and sale transactions on both dates, the reporting person held 0 shares of common stock, indicating no net accumulation of common stock holdings
- Significant insider sales at weighted-average prices of $11.98 and $12.5093 may be perceived by some investors as liquidity-taking by management
Insights
TL;DR: Insider executed matched buys and sales under a 10b5-1 plan, resulting in no net common stock holdings while retaining material option positions.
The reporting person executed purchases at $1.41 and contemporaneous sales at weighted-average prices of $11.98 and $12.5093 under a documented 10b5-1 plan. These transactions left 0 common shares held after each paired trade, while option positions remain sizable with 419,256 and 401,756 underlying shares reported post-transaction. For investors, this is a disclosure of liquidity activity by management rather than an operational update; it documents exercise/settlement activity and plan-based sales without showing accumulation of open common shares.
TL;DR: Transactions follow a pre-established 10b5-1 plan and include option exercises previously granted under the company's incentive plan.
The filing explicitly states the sales were made pursuant to a 10b5-1 plan adopted March 10, 2025, and references options granted under the 2019 Management Incentive Plan that vested on scheduled terms. The report discloses vesting breakdowns for time-based and performance-based awards and confirms full vesting of a June 12, 2019 grant as of March 28, 2024. These disclosures align with required insider reporting and provide transparency on governance and compensation mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 17,500 | $1.41 | $25K |
| Exercise | Common Stock | 17,500 | $1.41 | $25K |
| Sale | Common Stock | 17,500 | $12.5093 | $219K |
| Exercise | Option (Right to Purchase) | 15,000 | $1.41 | $21K |
| Exercise | Common Stock | 15,000 | $1.41 | $21K |
| Sale | Common Stock | 15,000 | $11.98 | $180K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.48 to $12.55. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. Approximately 23% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 77% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance. Approximately 20% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 80% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
